CVC Capital Seeks Partners to Fund €10.9 Billion Recordati Takeover

CVC Capital Partners is actively courting co-investors to shoulder the massive financial load of its proposed €10.9 billion acquisition of Italian pharmaceutical giant Recordati. This move signals the sheer scale of the deal, one of the largest European buyouts in the healthcare sector, and highlights the intricate capital structuring required to pull it off. The search for partners underscores the significant commitment needed to privatize a major, publicly listed drugmaker with a strong heritage and global footprint.

The proposed takeover of Recordati, a family-controlled company with a century-long history, represents a landmark transaction for the private equity industry in Italy. CVC's pursuit of co-investors is a standard yet critical tactic for spreading risk and pooling capital for a deal of this magnitude. It points to a calculated strategy to secure the necessary firepower while managing exposure, as the firm navigates the complexities of acquiring a stable, cash-generative business in the resilient pharmaceuticals market.

This development places intense scrutiny on the final financing architecture and the consortium that will ultimately back the bid. The involvement of additional investors could influence the deal's terms, timing, and regulatory reception. Success hinges on CVC's ability to assemble a confident syndicate, a process that will test market appetite for big-ticket European healthcare assets amid current economic uncertainties.